Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Chemed Corp (NY:CHE)

542.52 -6.04 (-1.10%)
Streaming Delayed Price Updated: 9:45 AM EDT, Aug 27, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Chemed Corp

< Previous 1 2 3 4 5 6 Next >
News headline image
1 Cash-Producing Stock with Exciting Potential and 2 Facing Challenges
Generating cash is essential for any business, but not all cash-rich companies are great investments. Some produce plenty of cash but fail to allocate it eff... 
Via StockStory
News headline image
1 Momentum Stock for Long-Term Investors and 2 We Brush Off
The stocks featured in this article have all approached their 52-week highs. When these price levels hit, it typically signals strong business execution, pos... 
Via StockStory
News headline image
1 Small-Cap Stock to Target This Week and 2 We Brush Off
Small-cap stocks can be incredibly lucrative investments because their lack of analyst coverage leads to frequent mispricings. However, these businesses (and... 
Via StockStory
News headline image
5 Insightful Analyst Questions From Chemed’s Q2 Earnings Call
Chemed’s Q2 results exceeded Wall Street’s expectations, prompting a positive response from investors. Management attributed the performance primarily to str... 
Via StockStory
Topics Earnings
Chemed Corp (NYSE:CHE) High Growth Stock Surges on Earnings Beat and Raised Guidance ↗
Via Chartmill
Topics Earnings
Chemed Corp (NYSE:CHE) Soars on Q1 Beat and Raised Full-Year Guidance ↗
Via Chartmill
News headline image
Chemed Q2 Earnings Call Highlights ↗
Chemed (NYSE:CHE) reported second-quarter 2026 results marked by stronger-than-expected performance at its VITAS hospice business, while Roto-Rooter delivered revenue growth but continued to face... 
Via MarketBeat
Topics Earnings Economy
News headline image
CHE Q2 Deep Dive: VITAS Growth and Roto-Rooter Marketing Pressures Shape Outlook
Healthcare services company Chemed Corporation (NYSE:CHE) announced better-than-expected revenue in Q2 CY2026, with sales up 8.8% year on year to $673.3 mill... 
Via StockStory
News headline image
Chemed (NYSE:CHE) Exceeds Q2 CY2026 Expectations
Healthcare services company Chemed Corporation (NYSE:CHE) reported revenue ahead of Wall Street’s expectations in Q2 CY2026, with sales up 8.8% year on year ... 
Via StockStory
News headline image
Chemed (CHE) Q2 Earnings: What To Expect
Healthcare services company Chemed Corporation (NYSE:CHE) will be reporting earnings this Tuesday after market close. Here’s what to look for. Chemed beat an... 
Via StockStory
News headline image
3 Healthcare Stocks We Keep Off Our Radar
Healthcare companies are pushing the status quo by innovating in areas like drug development and digital health. Players catalyzing medical advancements have... 
Via StockStory
News headline image
3 Unpopular Stocks We’re Skeptical Of
Wall Street’s bearish price targets for the stocks in this article signal serious concerns. Such forecasts are uncommon in an industry where maintaining cord... 
Via StockStory
Topics Economy
News headline image
3 Reasons to Sell CHE and 1 Stock to Buy Instead
Chemed trades at $513.71 and has moved in lockstep with the market. Its shares have returned 13.3% over the last six months while the S&P 500 has gained 8.4%... 
Via StockStory
Topics Artificial Intelligence Stocks
News headline image
A Look Back at Senior Health, Home Health & Hospice Stocks’ Q1 Earnings: Chemed (NYSE:CHE) Vs The Rest Of The Pack
Looking back on senior health, home health & hospice stocks’ Q1 earnings, we examine this quarter’s best and worst performers, including Chemed (NYSE:CHE) an... 
Via StockStory
Topics Economy
News headline image
1 Cash-Producing Stock Worth Your Attention and 2 Facing Headwinds
Generating cash is essential for any business, but not all cash-rich companies are great investments. Some produce plenty of cash but fail to allocate it eff... 
Via StockStory
News headline image
1 Profitable Stock for Long-Term Investors and 2 We Avoid
While profitability is essential, it doesn’t guarantee long-term success. Some companies that rest on their margins will lose ground as competition intensifi... 
Via StockStory
News headline image
2 Small-Cap Stocks with Solid Fundamentals and 1 We Avoid
Many small-cap stocks have limited Wall Street coverage, giving savvy investors the chance to act before everyone else catches on. But the flip side is that ... 
Via StockStory
News headline image
5 Revealing Analyst Questions From Chemed’s Q1 Earnings Call
Chemed’s first quarter results were well received by the market, reflecting stronger-than-expected performance at its VITAS hospice business and early signs ... 
Via StockStory
Topics Earnings
News headline image
Why Chemed (CHE) Stock Is Up Today
What Happened? Shares of healthcare services company Chemed Corporation (NYSE:CHE) jumped 8.8% in the afternoon session after the company reported first-quar... 
Via StockStory
Topics Earnings
News headline image
CHE Q1 Deep Dive: VITAS Drives Growth, Roto-Rooter Adapts to Higher Marketing Costs
Healthcare services company Chemed Corporation (NYSE:CHE) reported Q1 CY2026 results topping the market’s revenue expectations, with sales up 1.6% year on ye... 
Via StockStory
News headline image
Chemed (CHE) Q1 2026 Earnings Call Transcript ↗
Chemed (CHE) Q1 2026 Earnings Call Transcript 
Via The Motley Fool
Topics Earnings
News headline image
Chemed’s (NYSE:CHE) Q1 CY2026 Sales Top Estimates, Stock Jumps 10.2%
Healthcare services company Chemed Corporation (NYSE:CHE) beat Wall Street’s revenue expectations in Q1 CY2026, with sales up 1.6% year on year to $657.5 mil... 
Via StockStory
News headline image
Chemed (CHE) Q1 Earnings: What To Expect
Healthcare services company Chemed Corporation (NYSE:CHE) will be announcing earnings results this Thursday after market close. Here’s what investors should ... 
Via StockStory
Topics Artificial Intelligence
News headline image
3 Cash-Producing Stocks We’re Skeptical Of
A company that generates cash isn’t automatically a winner. Some businesses stockpile cash but fail to reinvest wisely, limiting their ability to expand. Cas... 
Via StockStory
News headline image
1 Profitable Stock on Our Buy List and 2 We Ignore
Even if a company is profitable, it doesn’t always mean it’s a great investment. Some struggle to maintain growth, face looming threats, or fail to reinvest ... 
Via StockStory
News headline image
Q4 Earnings Outperformers: Chemed (NYSE:CHE) And The Rest Of The Senior Health, Home Health & Hospice Stocks
Wrapping up Q4 earnings, we look at the numbers and key takeaways for the senior health, home health & hospice stocks, including Chemed (NYSE:CHE) and its pe... 
Via StockStory
Topics Economy
News headline image
3 Out-of-Favor Stocks Walking a Fine Line
The past year hasn't been kind to the stocks featured in this article. Each has tumbled to their lowest points in 12 months, leaving investors to decide whet... 
Via StockStory
News headline image
3 Reasons to Sell CHE and 1 Stock to Buy Instead
Over the past six months, Chemed’s shares (currently trading at $402.72) have posted a disappointing 11.9% loss while the S&P 500 was flat. This was partly d... 
Via StockStory
Topics Stocks
News headline image
1 Unpopular Stock That Deserves Some Love and 2 We Find Risky
When Wall Street turns bearish on a stock, it’s worth paying attention. These calls stand out because analysts rarely issue grim ratings on companies for fea... 
Via StockStory
News headline image
Why Chemed (CHE) Shares Are Plunging Today
Shares of healthcare services company Chemed Corporation (NYSE:CHE) fell 15.6% in the afternoon session after the company reported financial results for the fourth quarter of 2025 that missed Wall... 
Via StockStory
< Previous 1 2 3 4 5 6 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.